Experts Who Work With Omni-HC
Holly Kramen, JD – Compliance, Ethics & Commercialization
Holly Kramen is a proven compliance professional and attorney with vast experience in building and delivering Legal and Compliance programs for life science companies of varying sizes, therapeutic areas and unique needs. She has over 25 years of experience of integrating operations, regulatory, compliance and ethics with practicality, spark and common sense. Holly began her career at Pfizer in US Marketing and Commercial Operations where, in addition to contributing to the marketing launches of over a dozen blockbuster products, she successfully originated and incorporated commercial compliance into the company’s operations. Since Pfizer, Holly has held senior management positions in Compliance, Legal and Privacy in start-up med device, diagnostics and regenerative medicine companies. In her senior roles, she has designed and implemented US and international compliance for commercial and medical affairs, as well as delivered legal services. Holly also teaches in the Seton Hall Law school MSJ program and Compliance Certification programs. She has been a frequent speaker at industry conferences for more than a decade on a broad spectrum of compliance, commercialization and medical affairs topics.
Charles M. Alexander, MD - Medical Affairs & Outcomes
Dr. Alexander is a Medical Affairs and Outcomes Research specialist with experience in both private practice and industry clinical development. Most recently, he was Global Medical Director in the Global Medical Affairs department at Merck. During his tenure at Merck, Charlie worked in many therapeutic areas in Outcomes Research including cholesterol, atherosclerosis, hypertension, osteoporosis, and diabetes. He is the author of numerous scientific articles and a frequent reviewer for many medical journals. Dr. Alexander has been a member of the board of directors of the Southeastern Pennsylvania and Southern New Jersey Chapter of the American Diabetes Association since 2012 and is a Past President of the Academy of Pharmaceutical Physicians and Investigators (APPI). In addition, Dr Alexander also served as a volunteer consultant in endocrinology at the HealthLink Clinic in Southampton, Pennsylvania from 2010-2015. Dr. Alexander received his medical degree from the Keck School of Medicine of the University of Southern California where he also did his postgraduate training in internal medicine and endocrinology. Prior to joining Merck, he practiced diabetes, endocrinology and internal medicine in Los Angeles for ten years and was Clinical Professor of Medicine at the Keck School of Medicine of the University of Southern California. Dr. Alexander is board certified in Internal Medicine and Endocrinology-Metabolism and is a Fellow of both the American College of Physicians and the American College of Endocrinology.
Mary Alice Dwyer, PharmD - Medical Affairs & Patient Centricity
Mary Alice supports organizations seeking to elevate Medical Affairs as a strategic partner in the business. She is an experienced Medical Affairs leader with expertise in creating transformational initiatives, building and leading effective Medical Affairs teams, and implementing patient-centric practices. Dr. Dwyer adds value by enhancing Medical Affairs strategic focus, driving efficiency and effectiveness, ensuring launch preparedness, and creating meaningful metrics. As the Vice President of Global Medical Excellence (GME) at Astra Zeneca, Mary Alice developed and lead the GME function that elevated Medical Affairs deliverables through global, regional, and local medical partnerships while ensuring strong governance processes. She has also held roles as Head of US Field Medical and Vice President of US Medical Affairs at AstraZeneca. Prior to AstraZeneca, Mary Alice led scientific and medical teams for Takeda, Pharmacia, and Searle as well as worked in clinical drug development for Hoffmann-LaRoche and Glaxo.
William Fiedelman, MD - Medical Consulting & Medical Writing
Dr Fiedelman is an experienced pharmaceutical consultant and medical writer/editor. He has over 35 years of experience on the client and agency sides. Previously Bill was scientific director of Science & Medicine, a division of the Publicis Medical Education Group. Publicis had acquired Nelson Communications which Dr. Fiedelman had joined as senior vice president and medical director in October 1996. Bill's responsibilities included medical oversight for strategic planning, new business development, publication planning, editorial review, and medical writing. Dr. Fiedelman previously held the position of medical director at the Roerig Division of Pfizer Pharmaceuticals and at a number of medical communications agencies. He was also medical editor of the primary care journal Hospital Medicine from 1984 through 1999. Dr. Fiedelman is a graduate of New York Medical College, where he was elected to Alpha Omega Alpha Honor Medical Society. He completed residency training in pathology and pediatrics at the Mount Sinai Hospital and at Babies Hospital, Columbia-Presbyterian Medical Center, both in New York City; served as Lieutenant Commander, Medical Corps, United States Navy; practiced pediatrics; was appointed clinical instructor of pediatrics at The Mount Sinai School of Medicine; and was a medical investigator in the Office of Chief Medical Examiner, City of New York.
Peter J. Pitts - Healthcare Policy & Patient Strategy
Peter Pitts is President of the non-profit Center for Medicine in the Public Interest. a former FDA Associate Commissioner supervising FDA's Office of Public Affairs, and sits on numerous editorial and advisory boards including; The Patient Magazine, DIA's Therapeutic Innovation & Regulatory Science, and the Digital Health Council. In 2010, he was named by Modern Healthcare magazine as one of the 300 “most powerful people in American healthcare.”. Peter is a regular contributor to The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, Time, Newsweek, The Boston Globe, The Washington Times, The Chicago Tribune, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, The Lancet, Nature Biotechnology, The Journal of Life Sciences the BBC World Service, Fox News, CNBC, Bloomberg, The PBS NewsHour, NBC Dateline, The Daily Show with John Stewart, among others. He regularly gives healthcare policy presentations throughout Europe, Canada, and the United States, as well as in Russia, China, India, the Philippines, Malaysia, Saudi Arabia, Lebanon, Israel, Turkey, The United Arab Emirates, Jordan, Kenya, South Africa, Egypt, Algeria, Ukraine, Taiwan, Thailand, Japan, Brazil, Mexico, Vietnam, Indonesia, Singapore, Panama, Costa Rica, Argentina, and Columbia.
Lisa Griffin Vincent, PhD, MA, BSN - Clinical, HEOR, & Medical Affairs
Lisa Griffin Vincent is a proven leader in global clinical and medical affairs, HEOR, and regulatory policy across the life sciences, medical technology, and payer environments. She has an expertise in lifecycle evidence development, scientific and healthcare provider exchange, and regulatory policy interpretation and implementation, all enriched through her breadth of cross-functional experience. Dr. Vincent also has business leadership experience and understands the imperative to integrate functional strategies with the overall business strategy to maximize value. Lisa has held senior management roles at UnitedHealth Group’s Ingenix Pharmaceutical Services, Regulatory and Clinical Research Institute (RCRI), and Medtronic, in addition to other key roles. Dr. Vincent was president, Outcomes Research Solutions and chief regulatory officer at PatientPoint, a patient engagement and outcomes, and care coordination/population health management company at the point of care. She holds a bachelor’s in nursing, master’s in kinesiology, and doctorate in health services research & policy, all from the University of Minnesota.
Bruce T Rowan - Healthcare Technology
Bruce Rowan is a healthcare and healthcare technology leader tenured in Fortune 500 Global companies. Mr. Rowan has 20+ years of experience in the pharmaceutical and healthcare industries, and 16+ years in the HIT industry. Mr. Rowan is well versed in the issues facing the U.S. healthcare system including the shift toward quality care and health economics outcomes, the impact of cost and reimbursement pressures, and the movement toward adoption of HIT systems and data analytics. Mr. Rowan specializes in identifying and bridging the gaps between industry needs and healthcare technology systems, and the application of technology to create competitive advantages. Having led HIT strategy, and the conceptualization and development of HIT systems including patient registration, clinical data capture, clinical decision support, e-prescribing, patient adherence, and mobile applications, Mr. Rowan is highly knowledgeable in EHR, PHR, ERx, RCM, mHealth and all manner of HIT systems.
Joyce Ryan, DNP, MSN, FNP, RN
Joyce is a Board-Certified Nurse Practitioner with extensive experience in clinical development and medical affairs. She has held executive leadership positions at pharmaceutical and medical device companies building, challenging and engaging diverse teams to optimize organization output. Joyce helps clients achieve their commercial goals, overcome regulatory and clinical challenges. She is an expert speaker and educator and able to juggle many priorities. Prior to working in the healthcare products field, she was an ICU nurse where she learned how to work under tremendous pressure, remain flexible, and make quick decisions. Joyce can help clients identify, establish, and grow lasting KOL relationships that ultimately impact their business growth. Her therapeutic areas of expertise are infectious disease, GI, oncology, and primary care. Joyce has also been an expert witness for many years, providing depositions and expert witness testimony for several law firms.
William "Bill" Lief - Commercial Evaluation, Market & Patient Journey Research
Bill is a seasoned healthcare marketer with three decades of experience in medium and large healthcare companies. His most recent position was Executive Director of Commercial Research & Forecasting at Forest/Actavis (now Allergan) where he directed research support for Commercial Assessment, Business Development, Early Commercialization, Competitive Intelligence, Global Business, and other areas. Bill has conducted primary research with virtually every major physician specialty and payer type and innovated new approaches to make research results more robust. He is an expert in applying secondary and longitudinal data to pharmaceutical challenges as well as patient journey and promotional research. Bill is a former Co-chair of the Pharmaceutical Marketing Research Group national meeting, was a member of that organization’s Leadership Advisory Council in 2014 and currently sits on their Education Committee.
Bill has an MBA in Marketing and Finance from Columbia University Graduate School of Business where he received the Cadwell Davis Savage prize as that program’s top marketing graduate. Bill received his BA in Political Science from the University of Pennsylvania.
Bill has an MBA in Marketing and Finance from Columbia University Graduate School of Business where he received the Cadwell Davis Savage prize as that program’s top marketing graduate. Bill received his BA in Political Science from the University of Pennsylvania.